Google is teaming up with Swiss pharmaceutical company Novartis – specifically its Alcon eye care division – to bring its smart contact lens to market. Originally unveiled in January, the futuristic lens analyzes the user’s tears to consistently monitor blood glucose levels.
Google[x], the team known for its work on ‘moonshot’ projects within Google, will now collaborate with Alcon to develop the lens further. The final product will require “non-invasive sensors, microchips and other miniaturized electronics” to work accurately and seamlessly at all times.
So. Much. Tech.
Some of the biggest names in tech are coming to TNW Conference in Amsterdam this May.
Although diabetic patients are the target market, Google and Alcon said the “smart lens” technology could also offer vision correction for people living with presbyopia – a condition that makes it difficult to focus on near objects.
“Our dream is to use the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people,” Google’s Sergey Brin said. “We are very excited to work with Novartis to make this dream come true.”